Published in:
24-02-2023 | Original Article
Carcinogenic risk in the biliary epithelium of children with congenital biliary dilatation via the DNA damage repair pathway
Authors:
Hiroki Mori, Takayuki Noma, Yuji Morine, Hiroki Ishibashi, Mitsuo Shimada
Published in:
Surgery Today
|
Issue 10/2023
Login to get access
Abstract
Purposes
Congenital biliary dilatation (CBD) is a high-risk factor for biliary tract cancer (BTC). We previously reported the potential for carcinogenesis in the biliary epithelium of patients with CBD. In this study, we investigated potential carcinogenetic pathways, focusing on the DNA damage repair response, in children with CBD and compared the findings with those in adults.
Methods
We enrolled 6 children with CBD and 10 adults with CBD without BTC who underwent extrahepatic bile duct resections, plus 4 control patients who underwent pancreaticoduodenectomy for non-biliary cancer. Levels of phosphorylated histone H2AX (γH2AX), MRE11, and Ku-70 in the biliary tract epithelium were evaluated by immunohistochemistry.
Results
The levels of γH2AX, MRE11, and Ku-70 were significantly higher in the gallbladder epithelium and bile duct epithelium of both children and adults than in controls.
Conclusions
Children and adults with CBD might develop BTC via the DNA damage repair pathway, as evidenced by increased γH2AX, MRE11, and Ku-70 expression.